Pharmafile Logo
Pharmafocus logo
Advanced Search
pfizer_floor_plate

Pfizer breast cancer drug combo aces trial

April 7, 2014
Femera, Pfizer, breast cancer, oncology, palbociclib

News
sun_pharma

Under fire Ranbaxy sold to Sun Pharma for $4 billion

April 7, 2014
Manufacturing and Production, Sales and Marketing FDA, Ranbaxy, Sun Pharma, deal, hamburg, manufacturing

Sun Pharmaceutical Industries has bought struggling drugmaker Ranbaxy Laboratories in a deal that will see the two companies become the …

News
celgene_1_02_4

Celgene ‘stops Mylan entering market’

April 6, 2014
Sales and Marketing Celgene, Mylan, Revlimid, myeloma

Generic manufacturer Mylan is suing Celgene in a spat over allowing copycat versions of existing cancer drugs – Revlimid and …

News
Priddy image

Alzheimer’s disease: pharma’s greatest challenge

April 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, Alzheimer's, Alzheimer’s, Eisai, Lunt, Pfizer, galantamine, karran, priddy

Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …

Feature
tarceva_roche_2

NICE U-turn on Roche cancer drug

April 4, 2014
Medical Communications, Sales and Marketing NICE, Roche, Tarceva, U-turn

Roche’s lung cancer drug Tarceva has been given a reprieve to treat relapsed lung cancer patients in the NHS after …

News
Biocon image

Novartis sues Biocon

April 4, 2014
Sales and Marketing Biocon, Galvus, Gilead, Herceptin, Novartis, sofosbuvir

India’s status as a battleground for patent issues has been reinforced with the news that Novartis is suing Biocon over …

News

Fishawack buys JK Associates

April 4, 2014
Medical Communications 1010 Digital., Arbor Communications, Endpoint Medical Communications, JK Medical Communications, fishawack, jk associates

Medical communications firm Fishawack has acquired JK Associates in a bid to significantly expand the company’s presence in the US. …

News
Abbvie image

AbbVie drops EMA legal case after compromise

April 4, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, EMA, alltrials

AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …

News
atlas image

‘BrainSpan’ 3D technology could help drug development

April 4, 2014
Medical Communications, Sales and Marketing NIH, brainscan, digital, nimh

A new three-dimensional atlas of the developing human brain has been made available in the hope that it can help …

News
steve_oldfield_emg

EMG appoints new chair and officers

April 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMG, Sanofi, oldfield

Sanofi UK and Ireland’s managing director Steve Oldfield has been elected as chair of the European Medicines Group (EMG).  Oldfield …

Appointment
‘E-tattoo’ image

‘E-tattoo’ could help deliver drugs into patients

April 4, 2014
Medical Communications, Sales and Marketing device, digital, etattoo, nature, wearable tech

Researchers have created a new wearable device that is as thin as a temporary tattoo and can store and transmit …

News
gsk_glaxo

More manufacturing misery for GSK

April 4, 2014
Manufacturing and Production, Sales and Marketing GSK, Ireland, Paxil, cork, manufacturing

GlaxoSmithKline’s manufacturing woes are getting worse after the firm was hit with a second FDA warning in as many days. …

News
screen_shot_2014-04-03_at_16

Glythera makes two senior appointments

April 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing burns, evetts, glythera

Newcastle-based biotech firm Glythera has appointed Dr Nigel Burns as non-executive director and Ian Evetts as commercial director.  Burns (pictured) …

Appointment
FDA image

FDA slams GSK for manufacturing oversights

April 3, 2014
Manufacturing and Production FDA, GMP, GSK, Ireland, cork, mage, manufacturing

The FDA has warned GlaxoSmithKline that the US importation of products from the firm’s facility in Cork, Ireland could be …

News

Steve McCairns joins PCI as UK director

April 3, 2014
Manufacturing and Production, Research and Development, Sales and Marketing PCI, mccairns

Packaging firm PCI has welcomed Steve McCairns as its director of operations for its UK business.

  McCairns is a Lean …

Appointment
Glenis Willmott

EU votes for trial transparency

April 3, 2014
Research and Development, Sales and Marketing ABPI, EFPIA, EU, Goldacre, UK, alltrials, transparency, willmott

Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …

News

Lundbeck teams up with Lieber Institute

April 3, 2014
Research and Development, Sales and Marketing Astellas, AstraZeneca, Lundbeck, Pfizer, Roche, ability, brain, lieber, lilly

Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …

News
Merck Serono image

Research pact joins Pfizer and Merck Serono with academics

April 3, 2014
Research and Development, Sales and Marketing Lupus, Merck Serono, Pfizer, broad institute, emd, kidney

Merck’s US affiliate EMD Serono and Pfizer have entered into a research agreement with the Broad Institute to investigate autoimmune …

News
adrian_zambardino_

Langland appoints director of planning

April 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adrian Zambardino, Langland

Creative healthcare ad agency Langland has appointed Adrian Zambardino as its director of planning.  Zambardino has more than 25 years …

Appointment
Afrezza image

Inhaled insulin one step closer to approval

April 3, 2014
Sales and Marketing Afrezza, FDA, Mannkind, diabetes, type 1, type 2

After a rocky few years MannKind’s inhaled insulin Afrezza finally looks to be on the path to approval in the …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026